DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $232,878 | +10.9% | 939 | +7.3% | 0.03% | +13.0% |
| Q2 2023 | $210,005 | -8.4% | 875 | -3.7% | 0.02% | -11.5% |
| Q1 2023 | $229,185 | -59.2% | 909 | -57.0% | 0.03% | -58.7% |
| Q4 2022 | $561,562 | +4.0% | 2,116 | +1.2% | 0.06% | -8.7% |
| Q3 2022 | $540,000 | +8.0% | 2,090 | +6.0% | 0.07% | +19.0% |
| Q2 2022 | $500,000 | -7.9% | 1,972 | +6.5% | 0.06% | +13.7% |
| Q1 2022 | $543,000 | -11.3% | 1,852 | -0.4% | 0.05% | -29.2% |
| Q4 2021 | $612,000 | 0.0% | 1,860 | -7.5% | 0.07% | +41.2% |
| Q3 2021 | $612,000 | +14.8% | 2,011 | +1.2% | 0.05% | +21.4% |
| Q2 2021 | $533,000 | +22.0% | 1,987 | +2.4% | 0.04% | +16.7% |
| Q1 2021 | $437,000 | -35.5% | 1,941 | -36.4% | 0.04% | -35.7% |
| Q4 2020 | $678,000 | -36.3% | 3,052 | -38.2% | 0.06% | -38.5% |
| Q3 2020 | $1,064,000 | -9.6% | 4,940 | -25.8% | 0.09% | -38.9% |
| Q2 2020 | $1,177,000 | +99.8% | 6,654 | +56.3% | 0.15% | +69.3% |
| Q1 2020 | $589,000 | +53.8% | 4,256 | +70.4% | 0.09% | +109.5% |
| Q4 2019 | $383,000 | +23.9% | 2,497 | +16.7% | 0.04% | -10.6% |
| Q3 2019 | $309,000 | -35.6% | 2,139 | -36.3% | 0.05% | -39.0% |
| Q2 2019 | $480,000 | +60.0% | 3,358 | +47.6% | 0.08% | +97.4% |
| Q1 2019 | $300,000 | +35.7% | 2,275 | +6.4% | 0.04% | +34.5% |
| Q4 2018 | $221,000 | -4.7% | 2,139 | 0.0% | 0.03% | -14.7% |
| Q3 2018 | $232,000 | – | 2,139 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |